أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

pharma nord aps - glucosamine - capsule, hard - 400 milligrams per capsule - other antiinflammatory and antirheumatic agents, non-steroids; glucosamine

بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dechra veterinary products sa-nv - glucose monohydrate - eq. dextrose anhydrous 300 mg/ml - solution for infusion - 30 % - glucose monohydrate - glucose - cattle; goat; sheep

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

health+plus ltd - ascorbic acid; glucosamine sulfate - oral tablet

مالطا - الإنجليزية - Medicines Authority

elc group s.r.o. pobrezni 394/12, karlin 186 00 prague 8, czech republic - levodropropizine - syrup - levodropropizine 30 ml/5ml - cough and cold preparations

أستراليا - الإنجليزية - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - glucosamine hydrochloride - parenteral liquid/solution/suspension - glucosamine hydrochloride carbohydrate-glucose active 200.0 mg/ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - improve joint function

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - glucose, quantity: 500 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium bicarbonate - glucose 50% intravenous infusion is strongly hypertonic and may be used to reduce increased cerebrospinal pressure and/or oedema due to delirium tremens or acute alcoholic intoxication. it may also be used to treat severe hypoglycaemia due to an excess of insulin and to provide concentrated calories in total parenteral nutrition regimes.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - glucose monohydrate, quantity: 54.99 mg/ml (equivalent: glucose, qty 50 mg/ml) - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 31 july 2000: for fluid and carbohydrate depletion wherever a non-electrolyte fluid is required. in the treatment of hypoglycaemia. in the treatment of acute diarrhoeal disease. as a vehicle for the administration of other medications.

ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

safwa health products sdn. bhd. - glucosamine sulfate potassium chloride; sodium chondroitin sulfate -

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glucose 5%; sodium chloride 0.45% - solution for infusion - active: glucose 5% sodium chloride 0.45% excipient: water for injection - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glucose 2.5%; sodium chloride 0.45% - solution for infusion - active: glucose 2.5% sodium chloride 0.45% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.